Alzheimer’s Disease: Diagnosis & Treatment
New advances in blood tests for biomarkers mean earlier diagnosis and defined categories of Alzheimer’s disease enabling doctors to delay onset of symptoms, with lower costs to patients and higher accuracy. Guest:Howard Fillit, M.D., Co-Founder and Chief Science Officer, Alzheimer’s Drug Discovery Foundation.
PBS PASSPORT
Stream tens of thousands of hours of your PBS and local favorites with WETA+ and PBS Passport whenever and wherever you want. Catch up on a single episode or binge-watch full seasons before they air on TV.